Skip to Content

Health Privacy

WPF paper on collective privacy accepted to Privacy Law Scholar's Conference

WPF is pleased to announce that Executive Director Pam Dixon's paper on the topic of collective privacy was selected for inclusion at the Privacy Law Scholars Conference from a large and highly competitive field. The paper is now available at the PLSC website as a confidential download for conference attendees. ...

WPF advises FDA and HHS on informed consent guidance for medical research

The World Privacy Forum filed detailed comments regarding draft guidance on privacy and medical research to the U.S. Department of Health and Human Services and the U.S. Food and Drug Administration. The proposed guidance, Facilitating Understanding in Informed Consent, is related to consent for human subject research (medical research) and is particularly important. Currently, models of consent are in the process of going digital, which has created a number of challenging problems to solve. In the comments, WPF had several recommendations to improve consent and privacy.

WPF comments to NIST regarding its differential privacy guidance

WPF submitted comments to the National Institute of Standards and Technology regarding its Draft Guidelines for Evaluating Differential Privacy Guarantees . The comments approach the NIST Draft Guidance from a policy perspective, and urged changes to some parts of the definitional language in the Draft Guidance. Key areas of the ...

WPF advises HHS regarding proposed changes to standards for privacy under HIPAA

WPF provided detailed comments to the US Department of Health and Human Services regarding its proposal for changes to HIPAA regarding modifications to the Privacy Rule. Specifically, HHS proposed modifications to standards for the privacy of individually identifiable health information. WPF supports many of the changes proposed in the NPRM.

Emerging Technologies, Human Subject Research, and the Common Rule: High level overview of the 2023 OHRP Research Community Forum

Earlier this month, WPF attended a joint conference focused on the shifting dynamics of how the Common Rule that governs human subject research in the US will be interpreted amidst new technological shifts such as AI. The department of Health and Human Services is seeking to define what the next steps and new policy frameworks should be to ensure the Common Rule protects individuals in current and future research environments. Details on the presentations, conversations, and key takeaways in the post.

FTC takes first enforcement action under its Health Breach Notification Rule; also takes action against misrepresentation of HIPAA compliance

The FTC announced its first enforcement action under its Health Breach Notification Rule . This rule applies to entities that are not covered under HIPAA. The announcement of the proposed order was filed by the U.S. Department of Justice on behalf of the FTC against the " ...telehealth and prescription ...

WPF advises HHS on confidentiality of patient records re: alcohol and drug treatment records

The World Privacy Forum (WPF) submitted comments on an important Notice of Proposed Rulemaking that proposes modifications of the protection requirements for substance use disorder (SUD) treatment records. Currently, health records regarding treatment for Substance Use Disorders receive special protections under what is called Part 2 regulations , or, 42 ...

Statement of Pam Dixon at the FTC Open Commission Meeting regarding health privacy statements and consumer confusion

Thank you Chair and Commissioners. The profusion of health apps, websites and digital tools that provide consumers with assistance and insights about their health is a positive development. However, it has come at the cost of increasing privacy risks. One of these risks is that consumers are confused about when and where federal health privacy protections apply to their health information.

WPF advises Secretary's Advisory Committee on Human Research Protection regarding its proposed AI Framework

WPF recently reviewed and provided recommendations regarding a proposed AI Framework meant to apply to medical research involving human subjects. The issue of human subject research is a critically important one. In the US, The Common Rule (45 CFR subpart A) is a key regulation that protects people from unethical medical research. As research utilizing tools such as AI and SaMD -- software as a medical device -- grows in use, there is an urgent need to determine the proper ethical, legal, and regulatory framework for the use of these tools in the human subject research context. For this reason, WPF was pleased to review and provide recommendations to the Secretary's Advisory Committee on Human Research Protections, SACHRP, on its proposed AI Framework.

WPF urges HHS National Vaccine Advisory Committee to extend privacy protections of vaccination information

In public testimony September 15, 2021, WPF's Executive Director urged the Department of Health and Human Services National Vaccine Advisory Committee Committee to establish broadened protections for covid-19 vaccination data, including extending the existing CDC Guidance (from May 2021) prohibiting commercial marketing use of vaccination registration information or other vaccination ...

WPF supports CDC guidance prohibiting use of vaccine recipients' data for commercial marketing purposes, urges that protections are extended to proof of vaccination systems

WPF's Executive Director spoke today before the US Center For Disease Control's ACIP Committee regarding privacy protections for vaccine recipients' data. WPF supported the CDC’s prohibition on the use of vaccine recipient data for commercial marketing purposes. The CDC’s Vaccination Program Provider Requirement s , published in May 18, 2021, ...

WPF urges FTC Chair and Commissioners to update FTC Health Breach Notification Rule

The FTC held an historic open FTC Commission meeting, during which the Chair and Commissioners conducted their business openly and also provided an opportunity for public comments. The World Privacy Forum was selected to provide a public comment, which focused on the need to update the Health Breach Notification Rule. 

WPF Statement to the Civil Society Consultation on Sustainable Health Security Preparedness and Response, C20, 2021

The World Privacy Forum participated in the C20 Civil Society Consultation on Sustainable Health Security Preparedness 20 April, 2021, part of the preparatory work for the G20 health-related declaration. (Rome Declaration.) In our attached statement to the C20 / G20, we outline three key requirements to allow safe and sustainable health data ecosystem knowledge utilization, including privacy and effective data governance, interoperability, and robust inclusion of LMICs and vulnerable or marginalized populations in standards development.

WPF urges US Federal Trade Commission to re-examine data breach notification requirements for health data in Flo Health proposal

The World Privacy Forum has submitted comments to the FTC regarding its proposed consent order In the Matter of Flo Health, Inc. requesting that the FTC conduct further analysis regarding the FTC Health Data Breach Rule and its potential applicability to the alleged unconsented sharing of women's pregnancy, menstruation, mental ...

WPF comments on European Commission proposal for new Health Authority

The European Commission has proposed the creation of a new European Health Emergency Preparedness and Response Authority, HERA. WPF provided comments regarding the proposal, urging the Commission to ensure from the outset that HERA will fulfill its mission with a focus on data interoperability and will include specific data governance ...

World Health Organization updates its data sharing principles; WPF participant in external expert advisory group

This summer, the World Privacy Forum served as a member of the World Health Organization’s External Expert Group on Data Principles . We are pleased to announce that WHO has now published its updated data principles and data sharing policy, as of October 2020. While there are additional items that ...

COVID-19 and HIPAA: HHS’s Troubled Approach to Waiving Privacy and Security Rules for the Pandemic

The COVID-19 pandemic strained the U.S. health ecosystem in numerous ways, including putting pressure on the HIPAA privacy and security rules. The Department of Health and Human Services adjusted the privacy and security rules for the pandemic through the use of statutory and administrative HIPAA waivers. While some of the adjustments are appropriate for the emergency circumstances, there are also some meaningful and potentially unwelcome privacy and security consequences. At an appropriate time, the use of HIPAA waivers as a response to health care emergencies needs a thorough review. This report sets out the facts, identifies the issues, and proposes a roadmap for change.

HHS makes significant changes to COVID-19 reporting process

The Department of Health and Human services has announced major changes for hospitals' COVID-19 data reporting processes. HHS has also made changes to the types of data that hospitals must report, expanding the data collection. This includes new information requests for disaggregated information about adult and pediatric patients, to name a few of the changes. The reporting requirements do contain patient flows, but there are still unknown aspects to the new COVID-19 reporting requirements regarding individual-level data and certain privacy considerations.

Skip to Top